• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[脓毒症和脓毒性休克患者病情严重程度评估]

[Assessment of the severity of patient status in sepsis and septic shock].

作者信息

Rudnov V A, Beliaev S V, Nikolaev E K

出版信息

Anesteziol Reanimatol. 1995 Nov-Dec(6):9-11.

PMID:8713412
Abstract

A score for quantitative evaluation of the severity of clinical status has been created for a more objective assessment of the clinical status of patients with sepsis and septic shock. The system includes five sections: physiological parameters, level of respiratory support, age, localization of the focus, concomitant diseases. The final score represents a sum of scores for the above sections. ROC analysis demonstrated a higher prognostic value of the proposed score in comparison with the APACHE-II for patients with grave sepsis.

摘要

为了更客观地评估脓毒症和脓毒性休克患者的临床状况,已创建了一个用于定量评估临床状况严重程度的评分系统。该系统包括五个部分:生理参数、呼吸支持水平、年龄、感染灶定位、伴随疾病。最终得分是上述各部分得分的总和。ROC分析表明,对于严重脓毒症患者,与APACHE-II相比,所提出的评分具有更高的预后价值。

相似文献

1
[Assessment of the severity of patient status in sepsis and septic shock].[脓毒症和脓毒性休克患者病情严重程度评估]
Anesteziol Reanimatol. 1995 Nov-Dec(6):9-11.
2
[Choice of the optimal scale for evaluation of the severity of sepsis in children].
Anesteziol Reanimatol. 2001 Jan-Feb(1):51-3.
3
Mid-regional pro-adrenomedullin as a prognostic marker in sepsis: an observational study.中段肾上腺髓质素前体作为脓毒症的预后标志物:一项观察性研究。
Crit Care. 2005;9(6):R816-24. doi: 10.1186/cc3885. Epub 2005 Nov 15.
4
[Severe sepsis and septic shock].[严重脓毒症和脓毒性休克]
Rev Esp Anestesiol Reanim. 2007 Oct;54(8):484-98.
5
Early goal-directed therapy, corticosteroid, and recombinant human activated protein C for the treatment of severe sepsis and septic shock in the emergency department.急诊科早期目标导向治疗、皮质类固醇及重组人活化蛋白C治疗严重脓毒症和脓毒性休克
Acad Emerg Med. 2006 Jan;13(1):109-13. doi: 10.1197/j.aem.2005.08.005. Epub 2005 Dec 19.
6
Failure to implement evidence-based clinical guidelines for sepsis at the ED.急诊科未能实施基于证据的脓毒症临床指南。
Am J Emerg Med. 2006 Sep;24(5):553-9. doi: 10.1016/j.ajem.2006.01.012.
7
Practice and perception--a nationwide survey of therapy habits in sepsis.实践与认知——一项关于脓毒症治疗习惯的全国性调查
Crit Care Med. 2008 Oct;36(10):2719-25. doi: 10.1097/CCM.0b013e318186b6f3.
8
Pro-atrial natriuretic peptide is a prognostic marker in sepsis, similar to the APACHE II score: an observational study.与急性生理学及慢性健康状况评分系统II(APACHE II)评分相似,前心钠素是脓毒症的一项预后指标:一项观察性研究。
Crit Care. 2005 Feb;9(1):R37-45. doi: 10.1186/cc3015. Epub 2004 Dec 17.
9
Acute renal failure in patients with severe sepsis and septic shock--a significant independent risk factor for mortality: results from the German Prevalence Study.严重脓毒症和脓毒性休克患者的急性肾衰竭——死亡率的一个重要独立危险因素:德国患病率研究结果
Nephrol Dial Transplant. 2008 Mar;23(3):904-9. doi: 10.1093/ndt/gfm610. Epub 2007 Dec 7.
10
Implementation of a bundle of quality indicators for the early management of severe sepsis and septic shock is associated with decreased mortality.实施一系列用于严重脓毒症和脓毒性休克早期管理的质量指标与死亡率降低相关。
Crit Care Med. 2007 Apr;35(4):1105-12. doi: 10.1097/01.CCM.0000259463.33848.3D.